GSK plc
GSKGSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
Drugs in Pipeline
554
Phase 3 Programs
300
Upcoming Catalysts
20
Next Catalyst
Apr 30, 2026
8wMarket Overview
Stock performance and key metrics
20 upcoming, 0 past
Daprodustat small
Anaemia
enoxaparin
Thromboembolism
Chemotherapy
Melanoma
GSK 573719 +GW642444 125/25
Pulmonary Disease, Chronic Obstructive
GSK1562902A
Influenza
Priorix
Measles; Mumps; Rubella
GSK3511294 (Depemokimab)
Asthma
fondaparinux - UFH not indicated
Thromboembolism
Sumatriptan 25 mg
Migraine Disorders
Daratumumab
Multiple Myeloma
fluticasone propionate/salmeterol 250/50 DISKUS combination product
Pulmonary Disease, Chronic Obstructive
GW572016 (Lapatinib)
Neoplasms, Breast
Havrix™
Hepatitis A
0.254% w/w sodium fluoride and 5% KNO3
Tooth Erosion
fluticasone propionate inhalation solution
Asthma
Combined diphtheria, tetanus, acellular pertussis vaccine
Diphtheria
Linerixibat
Pruritus
PCV20
Respiratory Syncytial Virus Infections
GSK Biologicals' candidate Plasmodium falciparum malaria vaccine (257049)
Malaria
LAMICTAL extended-release
Epilepsy
GSK573719/GW642444 Inhalation Powder
Pulmonary Disease, Chronic Obstructive
Twinrix ™ Paediatric
Infections, Papillomavirus
darapladib
Retinopathy, Diabetic
GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM)
Infections, Papillomavirus
Bortezomib
Multiple Myeloma
MenitorixTM
Neisseria Meningitidis
Mepolizumab 300 mg
Hypereosinophilic Syndrome
Boostrix
Tetanus
Retigabine IR
Epilepsy
Insulin Glargine and Insulin Lispro
Diabetes Mellitus, Type 2
Herpes simplex candidate vaccine- adjuvanted GSK 208141
Prophylaxis for Herpes Simplex
Fondaparinux sodium
Embolism, Pulmonary
Belimumab 10 mg/kg plus standard therapy
Lupus Nephritis
Danazol
Primary Myelofibrosis
GSK Biologicals' HPV vaccine 580299
Infections, Papillomavirus
Influsplit Tetra™ vaccine produced by investigational process (IP)
Influenza
2-dose oral live attenuated G1P[8] human rotavirus vaccine
Infections, Rotavirus
Ezogabine: USAN Retigabine (International Nonproprietary Name)
Epilepsy
Mepolizumab 100mg
Asthma
DTPw-HBV/Hib Kft vaccine GSK323527A
Hepatitis B
Rosiglitazone
Diabetes Mellitus, Type 2
GSK573719/GW642444 62.5/25
Pulmonary Disease, Chronic Obstructive
Intravenous (IV) zanamivir
Influenza, Human
LEXIVA (GW433908)
HIV Infection
mometasone furoate
Rhinitis, Allergic, Perennial
Dutasteride 0.5 mg
Alopecia
Influenza vaccine GSK2321138A
Influenza
Pneumococcal conjugate vaccine GSK1024850A.
Infections, Streptococcal
mRNA-1273
Herpes Zoster
HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccine
Herpes Simplex Infection
PoliorixTM
Poliomyelitis
Fluticasone Furoate/GW642444
Asthma
Nitrofurantoin
Urinary Tract Infections
GSK573719/GW642444 125/25mcg
Pulmonary Disease, Chronic Obstructive
Ropinirole
Restless Legs Syndrome
Itraconazole 100mg capsules
Onychomycosis
alitretinoin
Eczema
pazopanib
Glioma
CTGel/ BPO Wash
Acne Vulgaris
CAPEOX
Colonic Neoplasms
Momelotinib
Primary Myelofibrosis
GW815SF HFA MDI
Bronchial Asthma
fluticasone furoate/vilanterol
Pulmonary Disease, Chronic Obstructive
Vilanterol
Asthma
Belimumab 1 mg/kg
Systemic Lupus Erythematosus
Liarozole
Ichthyosis, Lamellar
Sodium Monofluorophosphate
Dentine Hypersensitivity
Meningococcal vaccine GSK134612
Infections, Meningococcal
NC-503 (Anti-amyloidotic (AA) Agent)
Secondary (AA) Amyloidosis
HBV-MPL vaccine 208129
Hepatitis B
Azathioprine
Vasculitis
Belimumab 200 mg SC
Systemic Lupus Erythematosus
clindamycin / benzoyl peroxide gel
Acne Vulgaris
Umeclidinium
Hyperhidrosis
Paracetamol 1000 mg SR tablets
Pain
U0267
Psoriasis
Calcipotriene Foam
Psoriasis
GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum malaria vaccine 257049
Malaria
sodium fluoride
Enamel Erosion
BLU-5937
Cough
Tazarotene foam
Acne Vulgaris
CT Gel
Acne Vulgaris
GW685698X
Asthma
Belimumab
Systemic Lupus Erythematosus
Retpamulin Ointment, 1%
Skin Infections, Bacterial
Ruxolitinib
Primary Myelofibrosis
Best Available Therapy (BAT)
Primary Myelofibrosis (PMF)
Botulinum toxin A (GSK1358820)
Spasticity, Post-Stroke
Haemophilus influenzae type b and meningococcal serogroup C (vaccine)
Haemophilus Influenzae Type b
Dutasteride
Alopecia
U0267 Foam
Psoriasis
albuterol/salbutamol
Asthma
Combination Tablet of Treximet (sumatriptan/naproxen sodium)
Migraine Disorders
SB-275833 ointment, 1%
Impetigo
Rotarix (primary vaccination study)
Infections, Rotavirus
Fluticasone Furoate (FF)/GW642444 Inhalation Powder
Pulmonary Disease, Chronic Obstructive
Tritanrix™- HepB
Infections, Meningococcal
Herpes Zoster vaccine GSK 1437173A
Herpes Zoster
denosumab
Osteoporosis, Postmenopausal
Niraparib
Ovarian Neoplasms
AAAA
Chronic Hepatitis B
lisinopril
Hypertension
Lamivudine plus Polyethylene glyco-interferon alfa-2b
Chronic Hepatitis B
Sodium Fluoride Toothpaste
Caries
Infanrix+Hib™
Acellular Pertussis
GSK3511294
Asthma
sumatriptan succinate/naproxen sodium
Migraine
Sumatriptan and Naproxen Sodium
Migraine Disorders
ropinirole controlled-release (REQUIP CR) for RLS
Parkinson's Disease
Cervarix TM
Infections, Papillomavirus
fosamprenavir
HIV Infections
montelukast (5mg QD)
Asthma
GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)
Haemophilus Influenzae Type b
ropinirole Extended Release (XR)
Restless Legs Syndrome
HPV-16/18 L1/AS04
Infections, Papillomavirus
Pneumococcal vaccine GSK1024850A
Infections, Streptococcal
Otelixizumab
Diabetes Mellitus, Type 1
insulin glargine
Diabetes Mellitus, Type 2
Quadrivalent influenza GSK2282512A vaccine
Influenza
Experimental Denture Adhesive
Denture Retention
lamotrigine extended-release
Epilepsy
Fluticasone Furoate 100mcg / GW642444 (vilanterol) 25mcg
Pulmonary Disease, Chronic Obstructive
GSK1120212
Cancer
H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain)
Influenza
Depemokimab
Pulmonary Disease, Chronic Obstructive
Cervarix
Human Papillomavirus (HPV) Infection
Pneumococcal (vaccine)
Acellular Pertussis
GSK investigational vaccine GSK2340272A
Influenza
SB213503 lot 1
Tetanus
GSK1325760A
Pulmonary Arterial Hypertension
Thiomersal free trivalent influenza split vaccine 2003/2004
Influenza
Casopitant (GW679769) oral tablets
Vomiting
Fluticasone furoate
Rhinitis
Netivudine
HIV Infections
Engerix™-B
Hepatitis B
GW685698X Aqueous Nasal Spray
Rhinitis, Allergic, Seasonal
Efimosfermin alfa
Non-alcoholic Fatty Liver Disease
Abacavir sulfate
HIV Infections
FSC
Pulmonary Disease, Chronic Obstructive
Botulinum Toxin Type A
Glabellar Lines
Lamivudine
HIV Infections
Pentamidine isethionate
Pneumonia, Pneumocystis Carinii
Fluviral®
Influenza
HRV Liquid
Rotavirus
Lamivudine/Zidovudine
HIV Infections
Zidovudine
HIV Infections
Atovaquone
Pneumonia, Pneumocystis Carinii
Dutasteride 0.5mg capsule
Benign Prostatic Hyperplasia
albiglutide
Diabetes Mellitus, Type 2
Amprenavir
HIV Infections
Gepotidacin
Infections, Bacterial
Lovaza (omega-3-acid ethyl esters) [formerly known as Omacor] plus atorvastatin
Hypertriglyceridemia
Indinavir sulfate
HIV Infections
GSK1278863
Anaemia
Levocetirizine
Rhinitis
Ropinirole XL (formerly CR)
Parkinson Disease
GSK1358820
Urinary Bladder, Overactive
FF/GW642444 Inhalation Powder
Pulmonary Disease, Chronic Obstructive
GSK investigational vaccine GSK1557482A
Influenza
Fluticasone furoate 50mcg
Asthma
Casopitant
Nausea and Vomiting, Chemotherapy-Induced
fondaparinux
Fibrillation, Atrial
Cervarix™ (HPV-16/18 L1 VLP AS04)
Infections, Papillomavirus
ropinirole PR/XR
Parkinson Disease
Standard therapy (Including Immunosuppressants)
Systemic Lupus Erythematosus
GSK Biologicals' combined diphtheria, tetanus, acellular pertussis vaccine
Diphtheria
Fluarix/Influsplit SSW 2012-2013
Influenza
Rotarix
Infections, Rotavirus
human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
Cervical Cancer
Subjects received 3 doses of GSK Biologicals' HPV vaccine (580299) (Cervarix™)
Infections, Papillomavirus
lamotrigine
Schizophrenia
paroxetine
Social Anxiety Disorder
Retosiban
Obstetric Labour, Premature
MMRV
Rubella
1mg Glimepiride/10mg Atorvastatin FDC
Diabetes Mellitus, Type 2
Twinrix™ adult
Hepatitis B
FF/VI via ELLIPTA DPI
Asthma
GW642444 Inhalation Powder
Pulmonary Disease, Chronic Obstructive
Synflorix
Infections, Streptococcal
RSVPreF3 OA vaccine
Respiratory Syncytial Virus Infections
GSK573719
Pulmonary Disease, Chronic Obstructive
PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine
Infections, Rotavirus
Fluarix
Influenza
Boostrix™
Diphtheria
1% diclofenac sodium plus 3% menthol
Pain
GSK580299 (Cervarix)
Infections, Papillomavirus
Meningococcal vaccine GSK 134612
Meningococcal Infection
mepolizumab
Hypereosinophilia
Umeclidinium/Vilanterol 62.5/25 mcg
Pulmonary Disease, Chronic Obstructive
FF
Rhinitis, Allergic, Perennial
GSK investigational FluNG vaccine GSK2186877A, aged lot
Influenza
DTPw-HBV/Hib-MenAC conjugate vaccine
Diphtheria
Paclitaxel
Carcinoma
Pediarix
Poliomyelitis
Measles, Mumps, Rubella and Chickenpox (live vaccine)
Measles
GSK Biologicals' liquid human rotavirus vaccine 444563
Infections, Rotavirus
stannous fluoride
Dentin Sensitivity
PriorixTetra™
Rubella
Mepolizumab IV
Asthma
FF/UMEC/VI
Asthma
HRV PCV-free liquid vaccine
Infections, Rotavirus
GSK investigational vaccine 2186877A
Influenza
Denosumab 70 mg/mL
Fractures, Bone
GW815SF Salmeterol/Fluticasone propionate(HFA MDI)
Bronchial Asthma
Infanrix Hexa
Acellular Pertussis
Herpes Zoster Vaccine GSK1437173A
Herpes Zoster
Dostarlimab
Neoplasms, Rectal
Malaria Vaccine 257049
Malaria
GSK580299, GSK Biological's HPV vaccine
Infections, Papillomavirus
HZ/su vaccine GSK1437173A
Herpes Zoster
BW430C (lamotrigine)
Bipolar Disorder
Albiglutide 30 mg weekly
Diabetes Mellitus, Type 2
RSVPreF3 OA investigational vaccine
Respiratory Syncytial Virus Infections
Priorix®
Rubella
Daprodustat
Anaemia
HZ/su
Herpes Zoster
nicotine
Smoking Cessation
Mencevax™ACWY
Infections, Meningococcal
Adacel
Acellular Pertussis
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia)
Influenza
Meningitec™
Infections, Meningococcal
Investigational varicella vaccine
Chickenpox
Mencevax ACWY
Infections, Meningococcal
Prophylaxis: Diphtheria, tetanus and pertussis
Acellular Pertussis
Prednisolone
Arthritis, Rheumatoid
rosiglitazone/metformin
Diabetes Mellitus, Type 2
SOC
Asthma
Abciximab
Infarction, Myocardial
GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)
Influenza
GSK523338
Diabetes Mellitus, Type 2
Rosiglitazone 4 mg
Type 2 Diabetes Mellitus
GSK1605786A
Crohn's Disease
Fluticasone Furoate 100mcg/Vilanterol 25mcg
Pulmonary Disease, Chronic Obstructive
GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)
Herpes Zoster
Ropinirole prolonged release
Parkinson Disease
Pomalidomide
Multiple Myeloma
Belantamab mafodotin
Multiple Myeloma
Fluticasone propionate
Asthma
Lapatinib
Metastatic Breast Cancer
Influenza vaccine GSK2340272A
Influenza
Fluticasone Furoate/GW642444 Inhalation Powder 100/25mcg
Pulmonary Disease, Chronic Obstructive
10 valent pneumococcal conjugate vaccine
Infections, Rotavirus
Infanrix-IPV+Hib™
Acellular Pertussis
Oral Casopitant (GW679769)
Nausea and Vomiting, Chemotherapy-Induced
UMEC/VI Inhalation Powder 62.5/25 mcg via NDPI
Pulmonary Disease, Chronic Obstructive
Tritanrix-HepB/Meningitec conjugate vaccine
Diphtheria
Avandia
Insulin Resistance
Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A
Influenza
Lamictal
Epilepsy
Tenofovir disoproxil fumarate (TDF) tablets
Hepatitis B
Rosiglitazone Extended Release 2mg
Alzheimer's Disease
FluLaval™ Quadrivalent
Influenza
Rosiglitazone (BRL49653C)
Diabetes Mellitus, Type 2
diphtheria, tetanus, pertussis & Hib vaccine
Tetanus
Amoxicillin-Potassium Clavulanate Combination
Sinusitis, Acute
Fluoride
Dental Caries
62.5/25mcg
Pulmonary Disease, Chronic Obstructive
Losmapimod 7.5 mg twice daily
Acute Coronary Syndrome
Combined Hepatitis A and B vaccine
Hepatitis B
GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)
Infections, Meningococcal
Haemophilus influenzae type b- and meningococcal (vaccine)
Haemophilus Influenzae Type b
FLU-QIV
Respiratory Syncytial Virus Infections
glyburide
Diabetes Mellitus, Type 2
Sulfonylurea
Diabetes Mellitus
Salbutamol HFA-134a
Asthma
alosetron
Irritable Colon
Cervarix™
Infections, Papillomavirus
GW406381
Arthritis, Rheumatoid
HBV-MPL vaccine
Hepatitis B
DTPa-HBV-IPV/Hib
Haemophilus Influenzae Type b
Extended-release Bupropion Hydrochloride
Major Depressive Disorder (MDD)
DTPa-HBV-IPV/Hib (Infanrix hexa™)
Hepatitis B
Umeclidinium/vilanterol
Pulmonary Disease, Chronic Obstructive
Lyophilized mepolizumab
Asthma
GSK573719/GW642444 125/25
Pulmonary Disease, Chronic Obstructive
Umeclidinium bromide 62.5mcg
Pulmonary Disease, Chronic Obstructive
Live attenuated human rotavirus vaccine
Rotavirus Gastroenteritis
paracetamol + caffeine
Common Cold
HZ/su vaccine
Respiratory Syncytial Viruses
VI
Pulmonary Disease, Chronic Obstructive
Tiotropium
Pulmonary Disease, Chronic Obstructive
GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine
Haemophilus Influenzae Type b
GSK Bio's influenza vaccine GSK2186877A
Influenza
FF/VI
Pulmonary Disease, Chronic Obstructive
Depemokimab (GSK3511294)
Nasal Polyps
Fluticasone Furoate/ Vilanterol 200/25 mcg
Asthma
Pneumococcal conjugate vaccine GSK1024850A
Infections, Streptococcal
Mencevax™ ACWY
Infections, Meningococcal
fluticasone furoate + vilanterol
Asthma
Influsplit™ Tetra (Fluarix™ Tetra)
Influenza
Fluarix Quadrivalent
Influenza
Umeclidinium bromide
Pulmonary Disease, Chronic Obstructive
Fluticasone furoate/Vilanterol Inhalation Powder
Asthma
Havrix®
Hepatitis A
323U66 (Bupropion Hydrochloride Sustained Release)
Depressive Disorder
Engerix™-B (thiomersal-free) 20µg
Hepatitis B
valaciclovir HCl granules
Varicella
Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ)
Infections, Meningococcal
Tritanrix-HepB/Hib-MenAC
Whole Cell Pertussis
HBV-MPL 208129
Hepatitis B
GSK2269557 DPI
Pulmonary Disease, Chronic Obstructive
Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A.
Hepatitis B
SB-681323 Intravenous 3mg
Lung Injury, Acute
Metformin
Diabetes Mellitus, Type 2
RSV Vaccine (GSK3003891A) formulation 1
Respiratory Syncytial Virus Infections
RTS,S/AS01E
Malaria
intravenous ondansetron
Postoperative Nausea and Vomiting
GSK5784283
Asthma
SB-485232
Melanoma
Investigational MMRV(H)NS vaccine
Measles; Mumps; Rubella; Chickenpox
16448
Premature Ejaculation
GSK239512
Schizophrenia
GSK Biologicals HIV Vaccine 732462
AIDS
1278863A
Kidney Disease
foretinib (formerly GSK1363089 or XL880)
Carcinoma, Renal Cell
GSK Biologicals' GSK2340274A (two different formulations)
Influenza
Tritanrix™ HB+Hib
Tuberculosis
GS856553
Pain, Neuropathic
GBS Trivalent Vaccine
Bacterial Infection Due to Streptococcus, Group B
GSK malaria vaccine 257049 Vaccine
Malaria
GW869682
Obesity
A/turkey H5N1 vaccine
Influenza
GSK364735
Infection, Human Immunodeficiency Virus
albiglutide (GSK716155)
Diabetes Mellitus, Type 2
GSK4527226
Alzheimer's Disease
Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose
Salmonella Infections
Feladilimab
Multiple Myeloma
SB424323
Fibrillation, Atrial
GSK233705B
Pulmonary Disease, Chronic Obstructive
GSK835726 10mg
Rhinitis, Allergic, Seasonal
MenHibrix (Hib-MenCY-TT)
Neisseria Meningitidis
Aprepitant
Nausea and Vomiting
Varilrix (inactivated varicella vaccine)
Varicella
GW876008
Irritable Colon
Conjugated meningococcal ACWY-TT (vaccine)
Infections, Meningococcal
GSK256073 1mg
Diabetes Mellitus, Type 2
GSK2190915
Asthma
Ofatumumab
Lymphoma, Large-Cell, Diffuse
Cyclophosphamide
Lymphoma, Follicular
GW766944
Asthma
GSK2402968
Muscular Dystrophies
Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine)
Measles
GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A)
Virus Diseases
10mg atorvastatin
Dyslipidaemias
Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab)
Lymphoma, Non-Hodgkin
Prevenar 13
Acellular Pertussis
GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049
Malaria
Cobolimab
Melanoma
Fluticasone propionate 100mcg
Asthma
GSK2269557
Pulmonary Disease, Chronic Obstructive
Otilimab
Severe Acute Respiratory Syndrome
Paracetamol hot drink
Common Cold
5% KNO3 / 0.2542% NaF dentifrice with 0.5% spherical silica
Oral Hygiene
Iodine I 131 Tositumomab
Non-Hodgkin's Lymphoma
Luspatercept
Primary Myelofibrosis
Sodium bicarbonate and sodium fluoride
Oral Hygiene
GSK2202083A vaccine
Tetanus
fluorouracil
Neoplasms, Breast
FLU-Q-PAN H7N9 Formulation 1
Influenza, Human
salmeterol 50mcg
Asthma
GSK2894512 1% Cream
Psoriasis
GSK2982772
Psoriasis
Pandemic influenza vaccine (GSK1562902A) (adjuvanted or not)
Influenza
GSK1521498
Obesity
F2C22C/DL001Z
Influenza, Human
Lapatinib and Capecitabine
Neoplasms, Gastrointestinal Tract
HBV-MPL vaccine (208129)
Hepatitis B
rhEPO
Anaemia
Chlorproguanil-dapsone-artesunate (CDA)
Malaria
Belrestotug
Neoplasms, Head and Neck
HIV vaccine 732461
AIDS
GSK2798745 solution
Oedema, Pulmonary
meningococcal ACWY (vaccine)
Infections, Meningococcal
SB-480848 40 mg
Atherosclerosis
Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A)
Influenza
GSK's candidate Mycobacterium tuberculosis vaccine 692342
Tuberculosis
GSK2036874A vaccine
Haemophilus Influenzae Type b
ropinirole controlled release (CR)-RLS
Restless Legs Syndrome
Infanrix hexa Vaccine
Acellular Pertussis
GW493838
Neuropathic Pain
Meningococcal vaccine 134612
Infections, Meningococcal
NTHi-10-AS01E
Respiratory Disorders
Menactra®
Infections, Meningococcal
GSK835726 (10mg)
Rhinitis, Allergic, Seasonal
GW810781
HIV Infections
PegIFN
Hepatitis B
Nirogacestat
Multiple Myeloma
GSK1292263
Diabetes Mellitus, Type 2
Albiglutide (GSK716155) or exenatide
Diabetes Mellitus, Type 2
GSK2894512 0.5% Cream
Dermatitis, Atopic
Nicotine lower dose
Smoking
FP
Rhinitis
Adjuvanted RSVPreF3 vaccine
Respiratory Syncytial Virus Infections
Dose 1 GSK2586881
Lung Injury, Acute
FF/Vilanterol (VI; GW642444M)
Asthma
GSK2982772 60 mg
Arthritis, Rheumatoid
GSK5460025
Neoplasms, Colorectal
SB480848 40mg EC Tablet
Atherosclerosis
RTS,S/AS01E (SB257049)
Malaria
GW856553
Arthritis, Rheumatoid
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
Influenza
Run In Medication
Nasal Polyps
Influenza Vaccine GSK1247446A
Influenza
tositumomab and iodine I-131 tositumomab
Lymphoma, Non-Hodgkin
Cervarix vaccine
Infections, Papillomavirus
GSK2269557 100 MCG
Pulmonary Disease, Chronic Obstructive
GSK2336805 40 mg
Hepatitis C, Chronic
pazopanib and pemetrexed
Lung Cancer, Non-Small Cell
GSK163090 1 mg
Depressive Disorder
Live attenuated rotavirus vaccine
Infections, Rotavirus
GSK2118436
Melanoma and Brain Metastases
Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141
Prophylaxis Herpes Simplex
SB-480848
Atherosclerosis
GSK221149A
Obstetric Labour, Premature
letetresgene autoleucel (GSK3377794)
Neoplasms
SB497115
Purpura, Thrombocytopaenic, Idiopathic
GSK716155 subcutaneous injections
Diabetes Mellitus, Type 2
GSK4524101
Neoplasms
GSK Biologicals' HIV vaccine (732461)
AIDS
Docetaxel
Neoplasms
Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).
Influenza
Mepolizumab 750
Asthma
GW842166
Osteoarthritis, Knee
adjuvanted influenza vaccine
Influenza
Zalcitabine
HIV Infections
RSV vaccine GSK3003891A
Respiratory Syncytial Virus Infections
HPV 16/18 L1 AS04
Infections, Papillomavirus
vestipitant
Depressive Disorder and Anxiety Disorders
Human Rotavirus Vaccine - two different formulations
Infections, Rotavirus
rosiglitazone XR
Arthritis, Rheumatoid
Carbomer 980 (1146A)
Common Cold
pazopanib (GW786034)
Neoplasms, Uterine Cervix
GSK Biologicals' investigational TB vaccine (GSK692342)
Tuberculosis
RSVPreF3 OA investigational vaccine (GSK3844766A)
Respiratory Syncytial Virus Infections
Talnetant
Schizophrenia
retapamulin
Infections, Bacterial
GW642444
Pulmonary Disease, Chronic Obstructive
GSK4532990
Non-alcoholic Fatty Liver Disease
Fluticasone Propionate 100mcg via ACCUHALER/DISKUS
Asthma
Pneumococcal vaccine GSK2189242A
Infections, Streptococcal
Losmapimod tablets
Pulmonary Disease, Chronic Obstructive
Chloroquine 600mg
Malaria, Vivax
MenC-TT
Infections, Meningococcal
Bepirovirsen
Hepatitis B
Ranitidine hydrochloride
HIV Infections
GSK372475
Depressive Disorder
Flu mRNA (Formulation B1)
Influenza, Human
Tucaresol tablets 25 mg
HIV Infection
RSV MAT 60 µg
Respiratory Syncytial Virus Infections
FP 100
Asthma
oral nicotine
Smoking Dependence
Rotavirus
Infections, Rotavirus
DTPa-HBV-IPV/Hib (Infanrix-hexa™)
Hepatitis B
Lapatinib oral tablets
Neoplasms, Breast
nelarabine
Leukemia
GSK3228836
Hepatitis B
GSK2197870A
Neisseria Meningitidis
Lapatinib in combination with weekly paclitaxel
Neoplasms, Breast
GW685698X 200mcg,GW685698X 200mcg and 400mcg
Asthma
Losmapimod
Glomerulosclerosis, Focal Segmental
RTS,S/AS01E vaccine
Malaria
SB-773812
Schizophrenia
chlorambucil, tablets
Leukaemia, Lymphoblastic
Tositumomab and Iodine I 131 Tositumomab
Lymphoma, Non-Hodgkin
Nelfinavir mesylate
HIV Infections
SB705498 400 mg
Toothache
SB683699
Multiple Sclerosis, Relapsing-Remitting
683699
Crohn's Disease
GSK Biologicals' investigational vaccine GSK1562902A
Influenza
FFNS 110 mcg QD
Sinusitis, Acute
Topotecan/Docetaxel combination
Lung Cancer, Non-Small Cell
HPV9 High formulation
Cervical Intraepithelial Neoplasia
Pneumococcal vaccine GSK2189242A (formulation 1)
Infections, Streptococcal
Iodine I 131 Tositumomab Therapeutic Regimen
Lymphoma, Non-Hodgkin
Intravenous GR270773- Phospholipid Emulsion
Sepsis
Gemcitabine
Cancer
Unconjugated belantamab antibody
Multiple Myeloma
carboplatin
Primary Peritoneal Carcinoma
GSK2110183
Langerhans Cell Histiocytosis
Dose 4 QD
Asthma
Stavudine
HIV Infections
Prophylaxis: Diphtheria, tetanus, pertussis, poliovirus type 1, type 2 and type 3
Diphtheria
Herpes Zoster vaccine GSK1437173A Low Dose
Herpes Zoster
SRA737, gemcitabine, cisplatin
Advanced Solid Tumors
Firategrast 150 mg
Multiple Sclerosis
vinorelbine tartrate
Lung Cancer
NC-758 (Anti amyloidotic [Aß] agent)
Stroke
GSK2340274A
Influenza
Batefenterol
Pulmonary Disease, Chronic Obstructive
GSK Biologicals' influenza vaccine GSK1557482A
Influenza
Ritonavir
HIV Infections
SB-705498
Rhinitis
Fluticasone Furoate (FF)
Asthma
GSK573179
Pulmonary Disease, Chronic Obstructive
GW823093 15mg
Diabetes Mellitus, Type 2
Talarozole
Psoriasis
cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I 131 tositumomab.
Lymphoma, Non-Hodgkin
Non-adjuvanted HSV formulation 1
Herpes Simplex
Ambrisentan
Hypertension, Pulmonary
SB-742457
Alzheimer's Disease
GSK2245035
Asthma and Rhinitis
PNT2258
Lymphoma, Non-Hodgkin's
Rotavirus (vaccine)
Rotavirus Infections
GSK2330672
Cholestasis, Intrahepatic
GW870086X
Asthma
risperidone
Schizophrenia
Efavirenz
HIV Infections
Radafaxine
Major Depressive Disorder (MDD)
IONIS-HBVRx
Hepatitis B
GSK Biologicals' investigational TB vaccine GSK 692342
Tuberculosis
RTS,S/AS02A
Malaria
Mapatumumab
Carcinoma, Hepatocellular
SERETIDE Rotacaps
Asthma
GSK256066
Asthma
GSK's investigational vaccine 692342
Tuberculosis
0.12% chlorhexidine mouthrinse
Healthy Subjects
GSK2881078
Cachexia
Albaconazole 100mg
Onychomycosis
Tositumomab 450 mg
Lymphoma, Non-Hodgkin
GSK962040 (5 mg tablet)
Gastroparesis
100 micrograms Fluticasone propionate
Asthma
HRV vaccine
Infections, Rotavirus
GW501516 oral tablets
Dyslipidaemias
Pandemic influenza vaccine GSK2340272A
Influenza
GSK Biologicals' Candidate Tuberculosis (TB) Vaccine (692342)
Tuberculosis (TB)
Meningococcal (vaccine)
Infections, Meningococcal
Benzoyl peroxide gel
Acne Vulgaris
CV0701 mRNA COVID-19 Vaccine (Low dose)
SARS-CoV-2
GW679769
Depressive Disorder, Major
MMB
Primary Myelofibrosis (PMF)
Flu Pandemic mRNA_Dose level 1
Influenza, Human
Zanamivir
Influenza, Human
NC-503 (eprodisate disodium)
Diabetes Mellitus, Type 2
GSK1363089 (foretinib)
Neoplasms, Head and Neck
Nanomilled testosterone
Hypogonadism
GW677954
Metabolic Syndrome X
SRT2104
Diabetes Mellitus, Type 2
UMEC
Asthma
Candidate Influenza Vaccine GSK1247446A - 2 different formulations
Influenza
GW786034
Carcinoma, Renal Cell
GW685698/GW642444
Pulmonary Disease, Chronic Obstructive
topotecan
Lung Cancer, Small Cell
SRA737
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
GSK962040 25 mg
Gastroparesis
GSK189075
Diabetes Mellitus, Type 2
NTHi Mcat investigational vaccine (GSK3277511A)
Respiratory Disorders
CYT387
Primary Myelofibrosis
GSK3196165
Arthritis, Rheumatoid
GSK249320
Ischaemic Attack, Transient
eltrombopag
Purpura, Thrombocytopaenic, Idiopathic
HPV 16/18 VLP AS04
Infections, Papillomavirus
fluticasone propionate/salmeterol
Asthma
GW274150
Migraine Disorders
SB681323
Pain, Neuropathic
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Daprodustat small | Phase 3 | Anaemia | - | - |
enoxaparin | Phase 3 | Thromboembolism | - | - |
Chemotherapy | Phase 3 | Melanoma | - | - |
GSK 573719 +GW642444 125/25 | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
GSK1562902A | Phase 3 | Influenza | - | - |
Priorix | Phase 3 | Measles; Mumps; Rubella | - | - |
GSK3511294 (Depemokimab) | Phase 3 | Asthma | - | - |
fondaparinux - UFH not indicated | Phase 3 | Thromboembolism | - | - |
Sumatriptan 25 mg | Phase 3 | Migraine Disorders | - | - |
Daratumumab | Phase 3 | Multiple Myeloma | - | - |
fluticasone propionate/salmeterol 250/50 DISKUS combination product | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
GW572016 (Lapatinib) | Phase 3 | Neoplasms, Breast | - | - |
Havrix™ | Phase 3 | Hepatitis A | - | - |
0.254% w/w sodium fluoride and 5% KNO3 | Phase 3 | Tooth Erosion | - | - |
fluticasone propionate inhalation solution | Phase 3 | Asthma | - | - |
Combined diphtheria, tetanus, acellular pertussis vaccine | Phase 3 | Diphtheria | - | - |
Linerixibat | Phase 3 | Pruritus | - | - |
PCV20 | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
GSK Biologicals' candidate Plasmodium falciparum malaria vaccine (257049) | Phase 3 | Malaria | - | - |
LAMICTAL extended-release | Phase 3 | Epilepsy | - | - |
GSK573719/GW642444 Inhalation Powder | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Twinrix ™ Paediatric | Phase 3 | Infections, Papillomavirus | - | - |
darapladib | Phase 3 | Retinopathy, Diabetic | - | - |
GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM) | Phase 3 | Infections, Papillomavirus | - | - |
Bortezomib | Phase 3 | Multiple Myeloma | - | - |
MenitorixTM | Phase 3 | Neisseria Meningitidis | - | - |
Mepolizumab 300 mg | Phase 3 | Hypereosinophilic Syndrome | - | - |
Boostrix | Phase 3 | Tetanus | - | - |
Retigabine IR | Phase 3 | Epilepsy | - | - |
Insulin Glargine and Insulin Lispro | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Herpes simplex candidate vaccine- adjuvanted GSK 208141 | Phase 3 | Prophylaxis for Herpes Simplex | - | - |
Fondaparinux sodium | Phase 3 | Embolism, Pulmonary | - | - |
Belimumab 10 mg/kg plus standard therapy | Phase 3 | Lupus Nephritis | - | - |
Danazol | Phase 3 | Primary Myelofibrosis | - | - |
GSK Biologicals' HPV vaccine 580299 | Phase 3 | Infections, Papillomavirus | - | - |
Influsplit Tetra™ vaccine produced by investigational process (IP) | Phase 3 | Influenza | - | - |
2-dose oral live attenuated G1P[8] human rotavirus vaccine | Phase 3 | Infections, Rotavirus | - | - |
Ezogabine: USAN Retigabine (International Nonproprietary Name) | Phase 3 | Epilepsy | - | - |
Mepolizumab 100mg | Phase 3 | Asthma | - | - |
DTPw-HBV/Hib Kft vaccine GSK323527A | Phase 3 | Hepatitis B | - | - |
Rosiglitazone | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
GSK573719/GW642444 62.5/25 | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Intravenous (IV) zanamivir | Phase 3 | Influenza, Human | - | - |
LEXIVA (GW433908) | Phase 3 | HIV Infection | - | - |
mometasone furoate | Phase 3 | Rhinitis, Allergic, Perennial | - | - |
Dutasteride 0.5 mg | Phase 3 | Alopecia | - | - |
Influenza vaccine GSK2321138A | Phase 3 | Influenza | - | - |
Pneumococcal conjugate vaccine GSK1024850A. | Phase 3 | Infections, Streptococcal | - | - |
mRNA-1273 | Phase 3 | Herpes Zoster | - | - |
HSV vaccine or SB208141, GSK Biologicals' glycoprotein D (gD)-Alum/3-deacylated form of Monophosphoryl Lipid A (MPL) candidate genital herpes vaccine | Phase 3 | Herpes Simplex Infection | - | - |
PoliorixTM | Phase 3 | Poliomyelitis | - | - |
Fluticasone Furoate/GW642444 | Phase 3 | Asthma | - | - |
Nitrofurantoin | Phase 3 | Urinary Tract Infections | - | - |
GSK573719/GW642444 125/25mcg | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Ropinirole | Phase 3 | Restless Legs Syndrome | - | - |
Itraconazole 100mg capsules | Phase 3 | Onychomycosis | - | - |
alitretinoin | Phase 3 | Eczema | - | - |
pazopanib | Phase 3 | Glioma | - | - |
CTGel/ BPO Wash | Phase 3 | Acne Vulgaris | - | - |
CAPEOX | Phase 3 | Colonic Neoplasms | - | - |
Momelotinib | Phase 3 | Primary Myelofibrosis | - | - |
GW815SF HFA MDI | Phase 3 | Bronchial Asthma | - | - |
fluticasone furoate/vilanterol | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Vilanterol | Phase 3 | Asthma | - | - |
Belimumab 1 mg/kg | Phase 3 | Systemic Lupus Erythematosus | - | - |
Liarozole | Phase 3 | Ichthyosis, Lamellar | - | - |
Sodium Monofluorophosphate | Phase 3 | Dentine Hypersensitivity | - | - |
Meningococcal vaccine GSK134612 | Phase 3 | Infections, Meningococcal | - | - |
NC-503 (Anti-amyloidotic (AA) Agent) | Phase 3 | Secondary (AA) Amyloidosis | - | - |
HBV-MPL vaccine 208129 | Phase 3 | Hepatitis B | - | - |
Azathioprine | Phase 3 | Vasculitis | - | - |
Belimumab 200 mg SC | Phase 3 | Systemic Lupus Erythematosus | - | - |
clindamycin / benzoyl peroxide gel | Phase 3 | Acne Vulgaris | - | - |
Umeclidinium | Phase 3 | Hyperhidrosis | - | - |
Paracetamol 1000 mg SR tablets | Phase 3 | Pain | - | - |
U0267 | Phase 3 | Psoriasis | - | - |
Calcipotriene Foam | Phase 3 | Psoriasis | - | - |
GlaxoSmithKline (GSK) Biologicals' candidate Plasmodium falciparum malaria vaccine 257049 | Phase 3 | Malaria | - | - |
sodium fluoride | Phase 3 | Enamel Erosion | - | - |
BLU-5937 | Phase 3 | Cough | - | - |
Tazarotene foam | Phase 3 | Acne Vulgaris | - | - |
CT Gel | Phase 3 | Acne Vulgaris | - | - |
GW685698X | Phase 3 | Asthma | - | - |
Belimumab | Phase 3 | Systemic Lupus Erythematosus | - | - |
Retpamulin Ointment, 1% | Phase 3 | Skin Infections, Bacterial | - | - |
Ruxolitinib | Phase 3 | Primary Myelofibrosis | - | - |
Best Available Therapy (BAT) | Phase 3 | Primary Myelofibrosis (PMF) | - | - |
Botulinum toxin A (GSK1358820) | Phase 3 | Spasticity, Post-Stroke | - | - |
Haemophilus influenzae type b and meningococcal serogroup C (vaccine) | Phase 3 | Haemophilus Influenzae Type b | - | - |
Dutasteride | Phase 3 | Alopecia | - | - |
U0267 Foam | Phase 3 | Psoriasis | - | - |
albuterol/salbutamol | Phase 3 | Asthma | - | - |
Combination Tablet of Treximet (sumatriptan/naproxen sodium) | Phase 3 | Migraine Disorders | - | - |
SB-275833 ointment, 1% | Phase 3 | Impetigo | - | - |
Rotarix (primary vaccination study) | Phase 3 | Infections, Rotavirus | - | - |
Fluticasone Furoate (FF)/GW642444 Inhalation Powder | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Tritanrix™- HepB | Phase 3 | Infections, Meningococcal | - | - |
Herpes Zoster vaccine GSK 1437173A | Phase 3 | Herpes Zoster | - | - |
denosumab | Phase 3 | Osteoporosis, Postmenopausal | - | - |
Niraparib | Phase 3 | Ovarian Neoplasms | - | - |
AAAA | Phase 3 | Chronic Hepatitis B | - | - |
lisinopril | Phase 3 | Hypertension | - | - |
Lamivudine plus Polyethylene glyco-interferon alfa-2b | Phase 3 | Chronic Hepatitis B | - | - |
Sodium Fluoride Toothpaste | Phase 3 | Caries | - | - |
Infanrix+Hib™ | Phase 3 | Acellular Pertussis | - | - |
GSK3511294 | Phase 3 | Asthma | - | - |
sumatriptan succinate/naproxen sodium | Phase 3 | Migraine | - | - |
Sumatriptan and Naproxen Sodium | Phase 3 | Migraine Disorders | - | - |
ropinirole controlled-release (REQUIP CR) for RLS | Phase 3 | Parkinson's Disease | - | - |
Cervarix TM | Phase 3 | Infections, Papillomavirus | - | - |
fosamprenavir | Phase 3 | HIV Infections | - | - |
montelukast (5mg QD) | Phase 3 | Asthma | - | - |
GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108) | Phase 3 | Haemophilus Influenzae Type b | - | - |
ropinirole Extended Release (XR) | Phase 3 | Restless Legs Syndrome | - | - |
HPV-16/18 L1/AS04 | Phase 3 | Infections, Papillomavirus | - | - |
Pneumococcal vaccine GSK1024850A | Phase 3 | Infections, Streptococcal | - | - |
Otelixizumab | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
insulin glargine | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Quadrivalent influenza GSK2282512A vaccine | Phase 3 | Influenza | - | - |
Experimental Denture Adhesive | Phase 3 | Denture Retention | - | - |
lamotrigine extended-release | Phase 3 | Epilepsy | - | - |
Fluticasone Furoate 100mcg / GW642444 (vilanterol) 25mcg | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
GSK1120212 | Phase 3 | Cancer | - | - |
H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain) | Phase 3 | Influenza | - | - |
Depemokimab | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Cervarix | Phase 3 | Human Papillomavirus (HPV) Infection | - | - |
Pneumococcal (vaccine) | Phase 3 | Acellular Pertussis | - | - |
GSK investigational vaccine GSK2340272A | Phase 3 | Influenza | - | - |
SB213503 lot 1 | Phase 3 | Tetanus | - | - |
GSK1325760A | Phase 3 | Pulmonary Arterial Hypertension | - | - |
Thiomersal free trivalent influenza split vaccine 2003/2004 | Phase 3 | Influenza | - | - |
Casopitant (GW679769) oral tablets | Phase 3 | Vomiting | - | - |
Fluticasone furoate | Phase 3 | Rhinitis | - | - |
Netivudine | Phase 3 | HIV Infections | - | - |
Engerix™-B | Phase 3 | Hepatitis B | - | - |
GW685698X Aqueous Nasal Spray | Phase 3 | Rhinitis, Allergic, Seasonal | - | - |
Efimosfermin alfa | Phase 3 | Non-alcoholic Fatty Liver Disease | - | - |
Abacavir sulfate | Phase 3 | HIV Infections | - | - |
FSC | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Botulinum Toxin Type A | Phase 3 | Glabellar Lines | - | - |
Lamivudine | Phase 3 | HIV Infections | - | - |
Pentamidine isethionate | Phase 3 | Pneumonia, Pneumocystis Carinii | - | - |
Fluviral® | Phase 3 | Influenza | - | - |
HRV Liquid | Phase 3 | Rotavirus | - | - |
Lamivudine/Zidovudine | Phase 3 | HIV Infections | - | - |
Zidovudine | Phase 3 | HIV Infections | - | - |
Atovaquone | Phase 3 | Pneumonia, Pneumocystis Carinii | - | - |
Dutasteride 0.5mg capsule | Phase 3 | Benign Prostatic Hyperplasia | - | - |
albiglutide | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Amprenavir | Phase 3 | HIV Infections | - | - |
Gepotidacin | Phase 3 | Infections, Bacterial | - | - |
Lovaza (omega-3-acid ethyl esters) [formerly known as Omacor] plus atorvastatin | Phase 3 | Hypertriglyceridemia | - | - |
Indinavir sulfate | Phase 3 | HIV Infections | - | - |
GSK1278863 | Phase 3 | Anaemia | - | - |
Levocetirizine | Phase 3 | Rhinitis | - | - |
Ropinirole XL (formerly CR) | Phase 3 | Parkinson Disease | - | - |
GSK1358820 | Phase 3 | Urinary Bladder, Overactive | - | - |
FF/GW642444 Inhalation Powder | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
GSK investigational vaccine GSK1557482A | Phase 3 | Influenza | - | - |
Fluticasone furoate 50mcg | Phase 3 | Asthma | - | - |
Casopitant | Phase 3 | Nausea and Vomiting, Chemotherapy-Induced | - | - |
fondaparinux | Phase 3 | Fibrillation, Atrial | - | - |
Cervarix™ (HPV-16/18 L1 VLP AS04) | Phase 3 | Infections, Papillomavirus | - | - |
ropinirole PR/XR | Phase 3 | Parkinson Disease | - | - |
Standard therapy (Including Immunosuppressants) | Phase 3 | Systemic Lupus Erythematosus | - | - |
GSK Biologicals' combined diphtheria, tetanus, acellular pertussis vaccine | Phase 3 | Diphtheria | - | - |
Fluarix/Influsplit SSW 2012-2013 | Phase 3 | Influenza | - | - |
Rotarix | Phase 3 | Infections, Rotavirus | - | - |
human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine | Phase 3 | Cervical Cancer | - | - |
Subjects received 3 doses of GSK Biologicals' HPV vaccine (580299) (Cervarix™) | Phase 3 | Infections, Papillomavirus | - | - |
lamotrigine | Phase 3 | Schizophrenia | - | - |
paroxetine | Phase 3 | Social Anxiety Disorder | - | - |
Retosiban | Phase 3 | Obstetric Labour, Premature | - | - |
MMRV | Phase 3 | Rubella | - | - |
1mg Glimepiride/10mg Atorvastatin FDC | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Twinrix™ adult | Phase 3 | Hepatitis B | - | - |
FF/VI via ELLIPTA DPI | Phase 3 | Asthma | - | - |
GW642444 Inhalation Powder | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Synflorix | Phase 3 | Infections, Streptococcal | - | - |
RSVPreF3 OA vaccine | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
GSK573719 | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine | Phase 3 | Infections, Rotavirus | - | - |
Fluarix | Phase 3 | Influenza | - | - |
Boostrix™ | Phase 3 | Diphtheria | - | - |
1% diclofenac sodium plus 3% menthol | Phase 3 | Pain | - | - |
GSK580299 (Cervarix) | Phase 3 | Infections, Papillomavirus | - | - |
Meningococcal vaccine GSK 134612 | Phase 3 | Meningococcal Infection | - | - |
mepolizumab | Phase 3 | Hypereosinophilia | - | - |
Umeclidinium/Vilanterol 62.5/25 mcg | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
FF | Phase 3 | Rhinitis, Allergic, Perennial | - | - |
GSK investigational FluNG vaccine GSK2186877A, aged lot | Phase 3 | Influenza | - | - |
DTPw-HBV/Hib-MenAC conjugate vaccine | Phase 3 | Diphtheria | - | - |
Paclitaxel | Phase 3 | Carcinoma | - | - |
Pediarix | Phase 3 | Poliomyelitis | - | - |
Measles, Mumps, Rubella and Chickenpox (live vaccine) | Phase 3 | Measles | - | - |
GSK Biologicals' liquid human rotavirus vaccine 444563 | Phase 3 | Infections, Rotavirus | - | - |
stannous fluoride | Phase 3 | Dentin Sensitivity | - | - |
PriorixTetra™ | Phase 3 | Rubella | - | - |
Mepolizumab IV | Phase 3 | Asthma | - | - |
FF/UMEC/VI | Phase 3 | Asthma | - | - |
HRV PCV-free liquid vaccine | Phase 3 | Infections, Rotavirus | - | - |
GSK investigational vaccine 2186877A | Phase 3 | Influenza | - | - |
Denosumab 70 mg/mL | Phase 3 | Fractures, Bone | - | - |
GW815SF Salmeterol/Fluticasone propionate(HFA MDI) | Phase 3 | Bronchial Asthma | - | - |
Infanrix Hexa | Phase 3 | Acellular Pertussis | - | - |
Herpes Zoster Vaccine GSK1437173A | Phase 3 | Herpes Zoster | - | - |
Dostarlimab | Phase 3 | Neoplasms, Rectal | - | - |
Malaria Vaccine 257049 | Phase 3 | Malaria | - | - |
GSK580299, GSK Biological's HPV vaccine | Phase 3 | Infections, Papillomavirus | - | - |
HZ/su vaccine GSK1437173A | Phase 3 | Herpes Zoster | - | - |
BW430C (lamotrigine) | Phase 3 | Bipolar Disorder | - | - |
Albiglutide 30 mg weekly | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
RSVPreF3 OA investigational vaccine | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
Priorix® | Phase 3 | Rubella | - | - |
Daprodustat | Phase 3 | Anaemia | - | - |
HZ/su | Phase 3 | Herpes Zoster | - | - |
nicotine | Phase 3 | Smoking Cessation | - | - |
Mencevax™ACWY | Phase 3 | Infections, Meningococcal | - | - |
Adacel | Phase 3 | Acellular Pertussis | - | - |
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia) | Phase 3 | Influenza | - | - |
Meningitec™ | Phase 3 | Infections, Meningococcal | - | - |
Investigational varicella vaccine | Phase 3 | Chickenpox | - | - |
Mencevax ACWY | Phase 3 | Infections, Meningococcal | - | - |
Prophylaxis: Diphtheria, tetanus and pertussis | Phase 3 | Acellular Pertussis | - | - |
Prednisolone | Phase 3 | Arthritis, Rheumatoid | - | - |
rosiglitazone/metformin | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
SOC | Phase 3 | Asthma | - | - |
Abciximab | Phase 3 | Infarction, Myocardial | - | - |
GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations) | Phase 3 | Influenza | - | - |
GSK523338 | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Rosiglitazone 4 mg | Phase 3 | Type 2 Diabetes Mellitus | - | - |
GSK1605786A | Phase 3 | Crohn's Disease | - | - |
Fluticasone Furoate 100mcg/Vilanterol 25mcg | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A) | Phase 3 | Herpes Zoster | - | - |
Ropinirole prolonged release | Phase 3 | Parkinson Disease | - | - |
Pomalidomide | Phase 3 | Multiple Myeloma | - | - |
Belantamab mafodotin | Phase 3 | Multiple Myeloma | - | - |
Fluticasone propionate | Phase 3 | Asthma | - | - |
Lapatinib | Phase 3 | Metastatic Breast Cancer | - | - |
Influenza vaccine GSK2340272A | Phase 3 | Influenza | - | - |
Fluticasone Furoate/GW642444 Inhalation Powder 100/25mcg | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
10 valent pneumococcal conjugate vaccine | Phase 3 | Infections, Rotavirus | - | - |
Infanrix-IPV+Hib™ | Phase 3 | Acellular Pertussis | - | - |
Oral Casopitant (GW679769) | Phase 3 | Nausea and Vomiting, Chemotherapy-Induced | - | - |
UMEC/VI Inhalation Powder 62.5/25 mcg via NDPI | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Tritanrix-HepB/Meningitec conjugate vaccine | Phase 3 | Diphtheria | - | - |
Avandia | Phase 3 | Insulin Resistance | - | - |
Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A | Phase 3 | Influenza | - | - |
Lamictal | Phase 3 | Epilepsy | - | - |
Tenofovir disoproxil fumarate (TDF) tablets | Phase 3 | Hepatitis B | - | - |
Rosiglitazone Extended Release 2mg | Phase 3 | Alzheimer's Disease | - | - |
FluLaval™ Quadrivalent | Phase 3 | Influenza | - | - |
Rosiglitazone (BRL49653C) | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
diphtheria, tetanus, pertussis & Hib vaccine | Phase 3 | Tetanus | - | - |
Amoxicillin-Potassium Clavulanate Combination | Phase 3 | Sinusitis, Acute | - | - |
Fluoride | Phase 3 | Dental Caries | - | - |
62.5/25mcg | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Losmapimod 7.5 mg twice daily | Phase 3 | Acute Coronary Syndrome | - | - |
Combined Hepatitis A and B vaccine | Phase 3 | Hepatitis B | - | - |
GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix) | Phase 3 | Infections, Meningococcal | - | - |
Haemophilus influenzae type b- and meningococcal (vaccine) | Phase 3 | Haemophilus Influenzae Type b | - | - |
FLU-QIV | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
glyburide | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Sulfonylurea | Phase 3 | Diabetes Mellitus | - | - |
Salbutamol HFA-134a | Phase 3 | Asthma | - | - |
alosetron | Phase 3 | Irritable Colon | - | - |
Cervarix™ | Phase 3 | Infections, Papillomavirus | - | - |
GW406381 | Phase 3 | Arthritis, Rheumatoid | - | - |
HBV-MPL vaccine | Phase 3 | Hepatitis B | - | - |
DTPa-HBV-IPV/Hib | Phase 3 | Haemophilus Influenzae Type b | - | - |
Extended-release Bupropion Hydrochloride | Phase 3 | Major Depressive Disorder (MDD) | - | - |
DTPa-HBV-IPV/Hib (Infanrix hexa™) | Phase 3 | Hepatitis B | - | - |
Umeclidinium/vilanterol | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Lyophilized mepolizumab | Phase 3 | Asthma | - | - |
GSK573719/GW642444 125/25 | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Umeclidinium bromide 62.5mcg | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Live attenuated human rotavirus vaccine | Phase 3 | Rotavirus Gastroenteritis | - | - |
paracetamol + caffeine | Phase 3 | Common Cold | - | - |
HZ/su vaccine | Phase 3 | Respiratory Syncytial Viruses | - | - |
VI | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Tiotropium | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine | Phase 3 | Haemophilus Influenzae Type b | - | - |
GSK Bio's influenza vaccine GSK2186877A | Phase 3 | Influenza | - | - |
FF/VI | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Depemokimab (GSK3511294) | Phase 3 | Nasal Polyps | - | - |
Fluticasone Furoate/ Vilanterol 200/25 mcg | Phase 3 | Asthma | - | - |
Pneumococcal conjugate vaccine GSK1024850A | Phase 3 | Infections, Streptococcal | - | - |
Mencevax™ ACWY | Phase 3 | Infections, Meningococcal | - | - |
fluticasone furoate + vilanterol | Phase 3 | Asthma | - | - |
Influsplit™ Tetra (Fluarix™ Tetra) | Phase 3 | Influenza | - | - |
Fluarix Quadrivalent | Phase 3 | Influenza | - | - |
Umeclidinium bromide | Phase 3 | Pulmonary Disease, Chronic Obstructive | - | - |
Fluticasone furoate/Vilanterol Inhalation Powder | Phase 3 | Asthma | - | - |
Havrix® | Phase 3 | Hepatitis A | - | - |
323U66 (Bupropion Hydrochloride Sustained Release) | Phase 3 | Depressive Disorder | - | - |
Engerix™-B (thiomersal-free) 20µg | Phase 3 | Hepatitis B | - | - |
valaciclovir HCl granules | Phase 3 | Varicella | - | - |
Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ) | Phase 3 | Infections, Meningococcal | - | - |
Tritanrix-HepB/Hib-MenAC | Phase 3 | Whole Cell Pertussis | - | - |
HBV-MPL 208129 | Phase 3 | Hepatitis B | - | - |
GSK2269557 DPI | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
Adjuvanted Hepatitis B surface antigen (HBsAg) candidate vaccine GSK2231392A. | Phase 2 | Hepatitis B | - | - |
SB-681323 Intravenous 3mg | Phase 2 | Lung Injury, Acute | - | - |
Metformin | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
RSV Vaccine (GSK3003891A) formulation 1 | Phase 2 | Respiratory Syncytial Virus Infections | - | - |
RTS,S/AS01E | Phase 2 | Malaria | - | - |
intravenous ondansetron | Phase 2 | Postoperative Nausea and Vomiting | - | - |
GSK5784283 | Phase 2 | Asthma | - | - |
SB-485232 | Phase 2 | Melanoma | - | - |
Investigational MMRV(H)NS vaccine | Phase 2 | Measles; Mumps; Rubella; Chickenpox | - | - |
16448 | Phase 2 | Premature Ejaculation | - | - |
GSK239512 | Phase 2 | Schizophrenia | - | - |
GSK Biologicals HIV Vaccine 732462 | Phase 2 | AIDS | - | - |
1278863A | Phase 2 | Kidney Disease | - | - |
foretinib (formerly GSK1363089 or XL880) | Phase 2 | Carcinoma, Renal Cell | - | - |
GSK Biologicals' GSK2340274A (two different formulations) | Phase 2 | Influenza | - | - |
Tritanrix™ HB+Hib | Phase 2 | Tuberculosis | - | - |
GS856553 | Phase 2 | Pain, Neuropathic | - | - |
GBS Trivalent Vaccine | Phase 2 | Bacterial Infection Due to Streptococcus, Group B | - | - |
GSK malaria vaccine 257049 Vaccine | Phase 2 | Malaria | - | - |
GW869682 | Phase 2 | Obesity | - | - |
A/turkey H5N1 vaccine | Phase 2 | Influenza | - | - |
GSK364735 | Phase 2 | Infection, Human Immunodeficiency Virus | - | - |
albiglutide (GSK716155) | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
GSK4527226 | Phase 2 | Alzheimer's Disease | - | - |
Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose | Phase 2 | Salmonella Infections | - | - |
Feladilimab | Phase 2 | Multiple Myeloma | - | - |
SB424323 | Phase 2 | Fibrillation, Atrial | - | - |
GSK233705B | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
GSK835726 10mg | Phase 2 | Rhinitis, Allergic, Seasonal | - | - |
MenHibrix (Hib-MenCY-TT) | Phase 2 | Neisseria Meningitidis | - | - |
Aprepitant | Phase 2 | Nausea and Vomiting | - | - |
Varilrix (inactivated varicella vaccine) | Phase 2 | Varicella | - | - |
GW876008 | Phase 2 | Irritable Colon | - | - |
Conjugated meningococcal ACWY-TT (vaccine) | Phase 2 | Infections, Meningococcal | - | - |
GSK256073 1mg | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
GSK2190915 | Phase 2 | Asthma | - | - |
Ofatumumab | Phase 2 | Lymphoma, Large-Cell, Diffuse | - | - |
Cyclophosphamide | Phase 2 | Lymphoma, Follicular | - | - |
GW766944 | Phase 2 | Asthma | - | - |
GSK2402968 | Phase 2 | Muscular Dystrophies | - | - |
Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine) | Phase 2 | Measles | - | - |
GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A) | Phase 2 | Virus Diseases | - | - |
10mg atorvastatin | Phase 2 | Dyslipidaemias | - | - |
Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) | Phase 2 | Lymphoma, Non-Hodgkin | - | - |
Prevenar 13 | Phase 2 | Acellular Pertussis | - | - |
GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049 | Phase 2 | Malaria | - | - |
Cobolimab | Phase 2 | Melanoma | - | - |
Fluticasone propionate 100mcg | Phase 2 | Asthma | - | - |
GSK2269557 | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
Otilimab | Phase 2 | Severe Acute Respiratory Syndrome | - | - |
Paracetamol hot drink | Phase 2 | Common Cold | - | - |
5% KNO3 / 0.2542% NaF dentifrice with 0.5% spherical silica | Phase 2 | Oral Hygiene | - | - |
Iodine I 131 Tositumomab | Phase 2 | Non-Hodgkin's Lymphoma | - | - |
Luspatercept | Phase 2 | Primary Myelofibrosis | - | - |
Sodium bicarbonate and sodium fluoride | Phase 2 | Oral Hygiene | - | - |
GSK2202083A vaccine | Phase 2 | Tetanus | - | - |
fluorouracil | Phase 2 | Neoplasms, Breast | - | - |
FLU-Q-PAN H7N9 Formulation 1 | Phase 2 | Influenza, Human | - | - |
salmeterol 50mcg | Phase 2 | Asthma | - | - |
GSK2894512 1% Cream | Phase 2 | Psoriasis | - | - |
GSK2982772 | Phase 2 | Psoriasis | - | - |
Pandemic influenza vaccine (GSK1562902A) (adjuvanted or not) | Phase 2 | Influenza | - | - |
GSK1521498 | Phase 2 | Obesity | - | - |
F2C22C/DL001Z | Phase 2 | Influenza, Human | - | - |
Lapatinib and Capecitabine | Phase 2 | Neoplasms, Gastrointestinal Tract | - | - |
HBV-MPL vaccine (208129) | Phase 2 | Hepatitis B | - | - |
rhEPO | Phase 2 | Anaemia | - | - |
Chlorproguanil-dapsone-artesunate (CDA) | Phase 2 | Malaria | - | - |
Belrestotug | Phase 2 | Neoplasms, Head and Neck | - | - |
HIV vaccine 732461 | Phase 2 | AIDS | - | - |
GSK2798745 solution | Phase 2 | Oedema, Pulmonary | - | - |
meningococcal ACWY (vaccine) | Phase 2 | Infections, Meningococcal | - | - |
SB-480848 40 mg | Phase 2 | Atherosclerosis | - | - |
Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A) | Phase 2 | Influenza | - | - |
GSK's candidate Mycobacterium tuberculosis vaccine 692342 | Phase 2 | Tuberculosis | - | - |
GSK2036874A vaccine | Phase 2 | Haemophilus Influenzae Type b | - | - |
ropinirole controlled release (CR)-RLS | Phase 2 | Restless Legs Syndrome | - | - |
Infanrix hexa Vaccine | Phase 2 | Acellular Pertussis | - | - |
GW493838 | Phase 2 | Neuropathic Pain | - | - |
Meningococcal vaccine 134612 | Phase 2 | Infections, Meningococcal | - | - |
NTHi-10-AS01E | Phase 2 | Respiratory Disorders | - | - |
Menactra® | Phase 2 | Infections, Meningococcal | - | - |
GSK835726 (10mg) | Phase 2 | Rhinitis, Allergic, Seasonal | - | - |
GW810781 | Phase 2 | HIV Infections | - | - |
PegIFN | Phase 2 | Hepatitis B | - | - |
Nirogacestat | Phase 2 | Multiple Myeloma | - | - |
GSK1292263 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
Albiglutide (GSK716155) or exenatide | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
GSK2894512 0.5% Cream | Phase 2 | Dermatitis, Atopic | - | - |
Nicotine lower dose | Phase 2 | Smoking | - | - |
FP | Phase 2 | Rhinitis | - | - |
Adjuvanted RSVPreF3 vaccine | Phase 2 | Respiratory Syncytial Virus Infections | - | - |
Dose 1 GSK2586881 | Phase 2 | Lung Injury, Acute | - | - |
FF/Vilanterol (VI; GW642444M) | Phase 2 | Asthma | - | - |
GSK2982772 60 mg | Phase 2 | Arthritis, Rheumatoid | - | - |
GSK5460025 | Phase 2 | Neoplasms, Colorectal | - | - |
SB480848 40mg EC Tablet | Phase 2 | Atherosclerosis | - | - |
RTS,S/AS01E (SB257049) | Phase 2 | Malaria | - | - |
GW856553 | Phase 2 | Arthritis, Rheumatoid | - | - |
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Phase 2 | Influenza | - | - |
Run In Medication | Phase 2 | Nasal Polyps | - | - |
Influenza Vaccine GSK1247446A | Phase 2 | Influenza | - | - |
tositumomab and iodine I-131 tositumomab | Phase 2 | Lymphoma, Non-Hodgkin | - | - |
Cervarix vaccine | Phase 2 | Infections, Papillomavirus | - | - |
GSK2269557 100 MCG | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
GSK2336805 40 mg | Phase 2 | Hepatitis C, Chronic | - | - |
pazopanib and pemetrexed | Phase 2 | Lung Cancer, Non-Small Cell | - | - |
GSK163090 1 mg | Phase 2 | Depressive Disorder | - | - |
Live attenuated rotavirus vaccine | Phase 2 | Infections, Rotavirus | - | - |
GSK2118436 | Phase 2 | Melanoma and Brain Metastases | - | - |
Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141 | Phase 2 | Prophylaxis Herpes Simplex | - | - |
SB-480848 | Phase 2 | Atherosclerosis | - | - |
GSK221149A | Phase 2 | Obstetric Labour, Premature | - | - |
letetresgene autoleucel (GSK3377794) | Phase 2 | Neoplasms | - | - |
SB497115 | Phase 2 | Purpura, Thrombocytopaenic, Idiopathic | - | - |
GSK716155 subcutaneous injections | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
GSK4524101 | Phase 2 | Neoplasms | - | - |
GSK Biologicals' HIV vaccine (732461) | Phase 2 | AIDS | - | - |
Docetaxel | Phase 2 | Neoplasms | - | - |
Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A). | Phase 2 | Influenza | - | - |
Mepolizumab 750 | Phase 2 | Asthma | - | - |
GW842166 | Phase 2 | Osteoarthritis, Knee | - | - |
adjuvanted influenza vaccine | Phase 2 | Influenza | - | - |
Zalcitabine | Phase 2 | HIV Infections | - | - |
RSV vaccine GSK3003891A | Phase 2 | Respiratory Syncytial Virus Infections | - | - |
HPV 16/18 L1 AS04 | Phase 2 | Infections, Papillomavirus | - | - |
vestipitant | Phase 2 | Depressive Disorder and Anxiety Disorders | - | - |
Human Rotavirus Vaccine - two different formulations | Phase 2 | Infections, Rotavirus | - | - |
rosiglitazone XR | Phase 2 | Arthritis, Rheumatoid | - | - |
Carbomer 980 (1146A) | Phase 2 | Common Cold | - | - |
pazopanib (GW786034) | Phase 2 | Neoplasms, Uterine Cervix | - | - |
GSK Biologicals' investigational TB vaccine (GSK692342) | Phase 2 | Tuberculosis | - | - |
RSVPreF3 OA investigational vaccine (GSK3844766A) | Phase 2 | Respiratory Syncytial Virus Infections | - | - |
Talnetant | Phase 2 | Schizophrenia | - | - |
retapamulin | Phase 2 | Infections, Bacterial | - | - |
GW642444 | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
GSK4532990 | Phase 2 | Non-alcoholic Fatty Liver Disease | - | - |
Fluticasone Propionate 100mcg via ACCUHALER/DISKUS | Phase 2 | Asthma | - | - |
Pneumococcal vaccine GSK2189242A | Phase 2 | Infections, Streptococcal | - | - |
Losmapimod tablets | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
Chloroquine 600mg | Phase 2 | Malaria, Vivax | - | - |
MenC-TT | Phase 2 | Infections, Meningococcal | - | - |
Bepirovirsen | Phase 2 | Hepatitis B | - | - |
Ranitidine hydrochloride | Phase 2 | HIV Infections | - | - |
GSK372475 | Phase 2 | Depressive Disorder | - | - |
Flu mRNA (Formulation B1) | Phase 2 | Influenza, Human | - | - |
Tucaresol tablets 25 mg | Phase 2 | HIV Infection | - | - |
RSV MAT 60 µg | Phase 2 | Respiratory Syncytial Virus Infections | - | - |
FP 100 | Phase 2 | Asthma | - | - |
oral nicotine | Phase 2 | Smoking Dependence | - | - |
Rotavirus | Phase 2 | Infections, Rotavirus | - | - |
DTPa-HBV-IPV/Hib (Infanrix-hexa™) | Phase 2 | Hepatitis B | - | - |
Lapatinib oral tablets | Phase 2 | Neoplasms, Breast | - | - |
nelarabine | Phase 2 | Leukemia | - | - |
GSK3228836 | Phase 2 | Hepatitis B | - | - |
GSK2197870A | Phase 2 | Neisseria Meningitidis | - | - |
Lapatinib in combination with weekly paclitaxel | Phase 2 | Neoplasms, Breast | - | - |
GW685698X 200mcg,GW685698X 200mcg and 400mcg | Phase 2 | Asthma | - | - |
Losmapimod | Phase 2 | Glomerulosclerosis, Focal Segmental | - | - |
RTS,S/AS01E vaccine | Phase 2 | Malaria | - | - |
SB-773812 | Phase 2 | Schizophrenia | - | - |
chlorambucil, tablets | Phase 2 | Leukaemia, Lymphoblastic | - | - |
Tositumomab and Iodine I 131 Tositumomab | Phase 2 | Lymphoma, Non-Hodgkin | - | - |
Nelfinavir mesylate | Phase 2 | HIV Infections | - | - |
SB705498 400 mg | Phase 2 | Toothache | - | - |
SB683699 | Phase 2 | Multiple Sclerosis, Relapsing-Remitting | - | - |
683699 | Phase 2 | Crohn's Disease | - | - |
GSK Biologicals' investigational vaccine GSK1562902A | Phase 2 | Influenza | - | - |
FFNS 110 mcg QD | Phase 2 | Sinusitis, Acute | - | - |
Topotecan/Docetaxel combination | Phase 2 | Lung Cancer, Non-Small Cell | - | - |
HPV9 High formulation | Phase 2 | Cervical Intraepithelial Neoplasia | - | - |
Pneumococcal vaccine GSK2189242A (formulation 1) | Phase 2 | Infections, Streptococcal | - | - |
Iodine I 131 Tositumomab Therapeutic Regimen | Phase 2 | Lymphoma, Non-Hodgkin | - | - |
Intravenous GR270773- Phospholipid Emulsion | Phase 2 | Sepsis | - | - |
Gemcitabine | Phase 2 | Cancer | - | - |
Unconjugated belantamab antibody | Phase 2 | Multiple Myeloma | - | - |
carboplatin | Phase 2 | Primary Peritoneal Carcinoma | - | - |
GSK2110183 | Phase 2 | Langerhans Cell Histiocytosis | - | - |
Dose 4 QD | Phase 2 | Asthma | - | - |
Stavudine | Phase 2 | HIV Infections | - | - |
Prophylaxis: Diphtheria, tetanus, pertussis, poliovirus type 1, type 2 and type 3 | Phase 2 | Diphtheria | - | - |
Herpes Zoster vaccine GSK1437173A Low Dose | Phase 2 | Herpes Zoster | - | - |
SRA737, gemcitabine, cisplatin | Phase 2 | Advanced Solid Tumors | - | - |
Firategrast 150 mg | Phase 2 | Multiple Sclerosis | - | - |
vinorelbine tartrate | Phase 2 | Lung Cancer | - | - |
NC-758 (Anti amyloidotic [Aß] agent) | Phase 2 | Stroke | - | - |
GSK2340274A | Phase 2 | Influenza | - | - |
Batefenterol | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
GSK Biologicals' influenza vaccine GSK1557482A | Phase 2 | Influenza | - | - |
Ritonavir | Phase 2 | HIV Infections | - | - |
SB-705498 | Phase 2 | Rhinitis | - | - |
Fluticasone Furoate (FF) | Phase 2 | Asthma | - | - |
GSK573179 | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
GW823093 15mg | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
Talarozole | Phase 2 | Psoriasis | - | - |
cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I 131 tositumomab. | Phase 2 | Lymphoma, Non-Hodgkin | - | - |
Non-adjuvanted HSV formulation 1 | Phase 2 | Herpes Simplex | - | - |
Ambrisentan | Phase 2 | Hypertension, Pulmonary | - | - |
SB-742457 | Phase 2 | Alzheimer's Disease | - | - |
GSK2245035 | Phase 2 | Asthma and Rhinitis | - | - |
PNT2258 | Phase 2 | Lymphoma, Non-Hodgkin's | - | - |
Rotavirus (vaccine) | Phase 2 | Rotavirus Infections | - | - |
GSK2330672 | Phase 2 | Cholestasis, Intrahepatic | - | - |
GW870086X | Phase 2 | Asthma | - | - |
risperidone | Phase 2 | Schizophrenia | - | - |
Efavirenz | Phase 2 | HIV Infections | - | - |
Radafaxine | Phase 2 | Major Depressive Disorder (MDD) | - | - |
IONIS-HBVRx | Phase 2 | Hepatitis B | - | - |
GSK Biologicals' investigational TB vaccine GSK 692342 | Phase 2 | Tuberculosis | - | - |
RTS,S/AS02A | Phase 2 | Malaria | - | - |
Mapatumumab | Phase 2 | Carcinoma, Hepatocellular | - | - |
SERETIDE Rotacaps | Phase 2 | Asthma | - | - |
GSK256066 | Phase 2 | Asthma | - | - |
GSK's investigational vaccine 692342 | Phase 2 | Tuberculosis | - | - |
0.12% chlorhexidine mouthrinse | Phase 2 | Healthy Subjects | - | - |
GSK2881078 | Phase 2 | Cachexia | - | - |
Albaconazole 100mg | Phase 2 | Onychomycosis | - | - |
Tositumomab 450 mg | Phase 2 | Lymphoma, Non-Hodgkin | - | - |
GSK962040 (5 mg tablet) | Phase 2 | Gastroparesis | - | - |
100 micrograms Fluticasone propionate | Phase 2 | Asthma | - | - |
HRV vaccine | Phase 2 | Infections, Rotavirus | - | - |
GW501516 oral tablets | Phase 2 | Dyslipidaemias | - | - |
Pandemic influenza vaccine GSK2340272A | Phase 2 | Influenza | - | - |
GSK Biologicals' Candidate Tuberculosis (TB) Vaccine (692342) | Phase 2 | Tuberculosis (TB) | - | - |
Meningococcal (vaccine) | Phase 2 | Infections, Meningococcal | - | - |
Benzoyl peroxide gel | Phase 2 | Acne Vulgaris | - | - |
CV0701 mRNA COVID-19 Vaccine (Low dose) | Phase 2 | SARS-CoV-2 | - | - |
GW679769 | Phase 2 | Depressive Disorder, Major | - | - |
MMB | Phase 2 | Primary Myelofibrosis (PMF) | - | - |
Flu Pandemic mRNA_Dose level 1 | Phase 2 | Influenza, Human | - | - |
Zanamivir | Phase 2 | Influenza, Human | - | - |
NC-503 (eprodisate disodium) | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
GSK1363089 (foretinib) | Phase 2 | Neoplasms, Head and Neck | - | - |
Nanomilled testosterone | Phase 2 | Hypogonadism | - | - |
GW677954 | Phase 2 | Metabolic Syndrome X | - | - |
SRT2104 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
UMEC | Phase 2 | Asthma | - | - |
Candidate Influenza Vaccine GSK1247446A - 2 different formulations | Phase 2 | Influenza | - | - |
GW786034 | Phase 2 | Carcinoma, Renal Cell | - | - |
GW685698/GW642444 | Phase 2 | Pulmonary Disease, Chronic Obstructive | - | - |
topotecan | Phase 2 | Lung Cancer, Small Cell | - | - |
SRA737 | Phase 2 | Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL) | - | - |
GSK962040 25 mg | Phase 2 | Gastroparesis | - | - |
GSK189075 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
NTHi Mcat investigational vaccine (GSK3277511A) | Phase 2 | Respiratory Disorders | - | - |
CYT387 | Phase 2 | Primary Myelofibrosis | - | - |
GSK3196165 | Phase 2 | Arthritis, Rheumatoid | - | - |
GSK249320 | Phase 2 | Ischaemic Attack, Transient | - | - |
eltrombopag | Phase 2 | Purpura, Thrombocytopaenic, Idiopathic | - | - |
HPV 16/18 VLP AS04 | Phase 2 | Infections, Papillomavirus | - | - |
fluticasone propionate/salmeterol | Phase 2 | Asthma | - | - |
GW274150 | Phase 2 | Migraine Disorders | - | - |
SB681323 | Phase 2 | Pain, Neuropathic | - | - |
Pulmonary Disease, Chronic Obstructive
2 drugs in this indication
Dental Caries
1 drug in this indication
Thromboembolism
1 drug in this indication
Hepatitis B
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)